Advertisement

Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging

  • Batoul Pourgheysari
  • Leila Karimi
  • Raihaneh Bagheri
  • Soleiman Kheiri
Original Article
  • 21 Downloads

Abstract

Several studies have demonstrated T cell alteration and some features of immunosenescence in thalassemia major. Repeated alloimmunization converts naïve T-cells to memory cells and iron overload causes oxidative stress accelerating immune aging. To determine whether the alteration of T-cell cytokine is matched with early immune aging, the quantity of cytokine expressing T cells and their correlation to some immune aging markers were investigated. The proportion of IL2- and IFNγ expressing CD4+ and CD8+ T-cells was measured in 27 hepatitis B, C and HIV negative B-thalassemia patients and a control group aged 10–30 years, following stimulation for 6 h with streptococcus enterotoxin B and intracellular cytokine staining. This proportion then were analyzed versus the percentage of the T-cells expressing each phenotyping marker, CD27, CD28, CD57 and CCR7. CD4+ and CD8+ positive T cells expressing IL-2 were significantly lower in β-thalassemia major compared to matched controls, but not T cells expressing IFNγ. No significant difference was observed between splenectomized and non-splenectomized patients in cytokine expressing T cells. A negative correlation was noted between the percentage of T cells expressing IFNγ and T-cells expressing CD-27, but not other markers. Lower T cells expressing IL-2 may reveal the decline of naïve and central memory T cells and is likely to be a feature of early immune aging. Decreased antigenic stimulation and iron overload may help to prevent this phenomenon.

Keywords

Thalassemia major Immunosenescence Cytokine Intracellular T lymphocyte 

Notes

Acknowledgements

This study was supported by the Deputy of Research and Technology of the Shahrekord University of Medical Sciences with the Grant No. 916 obtained by first author.

Compliance with Ethical Standards

Conflict of interest

The authors declared no competing interests.

Ethics Committee

Ethical Approval for the study was obtained from the Shahrekord University of Medical Sciences Ethics Committee. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Rahimi Z, Muniz A, Akramipour R, Tofieghzadeh F, Mozafari H, Vaisi-Raygani A et al (2009) Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol Dis 42(2):140–143CrossRefGoogle Scholar
  2. 2.
    Kassab-Chekir A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, Amri F et al (2003) Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta Int J Clin Chem 338(1–2):79–86CrossRefGoogle Scholar
  3. 3.
    Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Breda L et al (2005) Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci 1054:118–123CrossRefGoogle Scholar
  4. 4.
    Schrier SL, Centis F, Verneris M, Ma L, Angelucci E (2003) The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep Commun Free Radic Res 8(5):241–245CrossRefGoogle Scholar
  5. 5.
    Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A (2003) Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit 9(1):RA19–RA22PubMedGoogle Scholar
  6. 6.
    Gharagozloo M, Karimi M, Amirghofran Z (2009) Double-faced cell-mediated immunity in β-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol 88(1):21–27CrossRefGoogle Scholar
  7. 7.
    Roshdy MN, Harfoush RA, Hamed NA, Morsi MG (2013) Quantitative estimation of interferon-gamma levels among Egyptian polytransfused haematology cases. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 19(5):490–494Google Scholar
  8. 8.
    Poland GA, Ovsyannikova IG, Kennedy RB, Lambert ND, Kirkland JL (2014) A systems biology approach to the effect of aging, immunosenescence and vaccine response. Curr Opin Immunol 29:62–68CrossRefGoogle Scholar
  9. 9.
    Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM (1999) Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17(1):82–94CrossRefGoogle Scholar
  10. 10.
    Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH et al (2003) Memory inflation: continuous accumulation of antiviral CD8 + T cells over time. J Immunol (Baltimore, Md: 1950) 170(4):2022–2029CrossRefGoogle Scholar
  11. 11.
    Voskou S, Aslan M, Fanis P, Phylactides M, Kleanthous M (2015) Oxidative stress in beta-thalassaemia and sickle cell disease. Redox Biol 6:226–239CrossRefGoogle Scholar
  12. 12.
    Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A (2005) Human immunosenescence: is it infectious? Immunol Rev 205(1):257–268CrossRefGoogle Scholar
  13. 13.
    Sari TT, Gatot D, Akib AA, Bardosono S, Hadinegoro SR, Harahap AR et al (2014) Immune response of thalassemia major patients in Indonesia with and without splenectomy. Acta Med Indones 46(3):217–225PubMedGoogle Scholar
  14. 14.
    Velasquez SY, Garcia LF, Opelz G, Alvarez CM, Susal C (2013) Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-gamma and IL-2. Transplantation 96(2):154–161CrossRefGoogle Scholar
  15. 15.
    Provinciali M, Moresi R, Donnini A, Lisa RM (2009) Reference values for CD4+ and CD8+ T lymphocytes with naive or memory phenotype and their association with mortality in the elderly. Gerontology 55(3):314–321CrossRefGoogle Scholar
  16. 16.
    Li G, Ju J, Weyand CM, Goronzy JJ (2015) Age-associated failure to adjust type I IFN receptor signaling thresholds after T cell activation. J Immunol (Baltimore, Md: 1950) 195(3):865–874CrossRefGoogle Scholar
  17. 17.
    Pourgheysari B, Bruton R, Parry H, Billingham L, Fegan C, Murray J et al (2010) The number of cytomegalovirus-specific CD4 + T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4 + T-cell repertoire. Blood 116(16):2968–2974CrossRefGoogle Scholar
  18. 18.
    Jang TY, Lin PC, Huang CI, Liao YM, Yeh ML, Zeng YS et al (2017) Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients. PLoS ONE 12(6):e0178883CrossRefGoogle Scholar
  19. 19.
    Mahzounieh M, Ghorani M, Karimi A, Pourgheysari B, Nikoozad R (2015) Prevalence of human T-lymphotropic virus types I and II in patients with hematological disorders in Isfahan, Iran. Jundishapur J Microbiol 8(6):e17201PubMedPubMedCentralGoogle Scholar
  20. 20.
    Al-Awadhi AM, Alfadhli SM, Al-Khaldi D, Borhama M, Borusly M (2010) Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients. Int J Lab Hematol 32(2):191–196CrossRefGoogle Scholar
  21. 21.
    Gharagozloo M, Bagherpour B, Tahanian M, Oreizy F, Amirghofran Z, Sadeghi HM et al (2009) Premature senescence of T lymphocytes from patients with beta-thalassemia major. Immunol Lett 122(1):84–88CrossRefGoogle Scholar
  22. 22.
    Pourgheysari B, Karimi L, Beshkar P (2016) Alteration of T cell subtypes in beta-thalassaemia major: impact of ferritin level. JCDR 10(2):Dc8–Dc14Google Scholar
  23. 23.
    Kallies A (2008) Distinct regulation of effector and memory T-cell differentiation. Immunol Cell Biol 86(4):325–332CrossRefGoogle Scholar
  24. 24.
    Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S et al (2011) Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol 86(12):1001–1006CrossRefGoogle Scholar
  25. 25.
    Bozdogan G, Erdem E, Demirel GY, Yildirmak Y (2010) The role of Treg cells and FoxP3 expression in immunity of beta-thalassemia major AND beta-thalassemia trait patients. Pediatr Hematol Oncol 27(7):534–545CrossRefGoogle Scholar
  26. 26.
    Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A (2006) CD4 + CD25 + T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence (Orlando, Fla). Clin Immunol 119(3):307–316CrossRefGoogle Scholar
  27. 27.
    Al-Ofairi BA, Barakat AB, Ghanim Hel D, Shehata IH, El-Sayed MH (2011) A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection. Egypt J Immunol 18(1):61–76PubMedGoogle Scholar
  28. 28.
    Butthep P, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S (2015) Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients. Blood Cells Mol Dis 54(2):170–176CrossRefGoogle Scholar
  29. 29.
    Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA (2007) The cytomegalovirus-specific CD4 + T-cell response expands with age and markedly alters the CD4 + T-cell repertoire. J Virol 81(14):7759–7765CrossRefGoogle Scholar
  30. 30.
    Mendez-Lagares G, Diaz L, Correa-Rocha R, Leon Leal JA, Ferrando-Martinez S, Ruiz-Mateos E et al (2013) Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects. Clin Microbiol Infect 19(6):558–565CrossRefGoogle Scholar
  31. 31.
    Albareda MC, Olivera GC, De Rissio AM, Postan M (2010) Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children. Am J Trop Med Hyg 82(5):861–864CrossRefGoogle Scholar
  32. 32.
    Kern F, Khatamzas E, Surel I, Frommel C, Reinke P, Waldrop SL et al (1999) Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 29(9):2908–2915CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  1. 1.Department of Hematology, Medical Plants Research Center, Basic Health Sciences InstituteShahrekord University of Medical SciencesShahrekordIran
  2. 2.Cellular and Molecular Research Center, Basic Health Sciences InstituteShahrekord University of Medical SciencesRahmatiyeh, ShahrekordIran
  3. 3.School of MedicineTehran University of Medical SciencesTehranIran
  4. 4.Social Determinants of Health Research CenterShahrekord University of Medical SciencesShahrekordIran

Personalised recommendations